Anesthesiology Doctors in Morristown, NJ Accepting Medicare

67 Anesthesiology doctors found. Showing 61 - 67

Brian Lucas, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 800-991-9133    Fax: 201-943-8733

Dr. Lisa Longworth-gatto, DO Anesthesiology - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 160 Hanover Avenue, Morristown, NJ 07962 Phone: 973-538-2334

Thomas Murray, MD, PHD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 800-991-9133    Fax: 201-943-8733

Alexander Geoffrey Eng, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 973-971-5000

Dr. Jenna L Fine, DO Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 973-971-7550    Fax: 973-290-7364

Sameer Merchant, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 800-991-9133    Fax: 201-943-8733

Richard Stennett, MD, MPH Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Madison Ave, Morristown, NJ 07960 Phone: 800-991-9133    Fax: 201-943-8733

News Archive

New behavioral therapy improves antidepressant treatment of OCD

NIMH grantees have demonstrated that a form of behavioral therapy can augment antidepressant treatment of obsessive compulsive disorder (OCD) better than an antipsychotic.

Positive results from Neuraltus NP002 Phase 1/2 study for levodopa-induced dyskinesias in Parkinson's disease

Neuraltus Pharmaceuticals, a privately held biopharmaceutical company dedicated to developing and commercializing high-impact therapeutics that address critical unmet medical needs, primarily for the treatment of neurodegenerative diseases, announced today top-line results from the Company's Phase 1/2 clinical study of NP002 for the treatment of dyskinesias (muscle movement disorders) resulting from levodopa therapy for patients with Parkinson's disease.

New oral blood-thinning drugs may have dangerous interactions when taken with prescription drugs : Study

Three new oral blood-thinning drugs nearing approval by the Food and Drug Administration are more convenient than the standard drug Coumadin® because they do not require monthly visits to adjust doses.

miRNAs may improve risk prediction in CAD

Single microRNAs derived from peripheral blood predict cardiovascular mortality in patients with coronary artery disease, German research shows.

Read more Medical News

› Verified 1 days ago

• 1
• 2
• 3
• 4(current)